Haemophagocytosis in bone marrow aspirates in patients with COVID-19.
作者信息
Debliquis Agathe, Harzallah Inès, Mootien Joy Y, Poidevin Antoine, Labro Guylaine, Mejri Amira, Lamarque Mathilde, Kuteifan Khaldoun, Drénou Bernard
机构信息
Département d'Hématologie, Groupe Hospitalier de la région Mulhouse Sud Alsace, Mulhouse, France.
Service de Réanimation médicale, Groupe Hospitalier de la région Mulhouse Sud Alsace, Mulhouse, France.
出版信息
Br J Haematol. 2020 Jul;190(2):e70-e73. doi: 10.1111/bjh.16860. Epub 2020 Jun 12.
Abstract
摘要
相似文献
1
Haemophagocytosis in bone marrow aspirates in patients with COVID-19.新型冠状病毒肺炎患者骨髓穿刺物中的噬血细胞现象
Br J Haematol. 2020 Jul;190(2):e70-e73. doi: 10.1111/bjh.16860. Epub 2020 Jun 12.
2
Haemophagocytic lymphohistiocytosis in COVID-19 cases?新冠病毒感染病例中的噬血细胞性淋巴组织细胞增生症？
Tidsskr Nor Laegeforen. 2020 Mar 23;140(6). doi: 10.4045/tidsskr.20.0240. Print 2020 Apr 21.
3
Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection.新型冠状病毒感染中的噬血细胞性淋巴组织细胞增生症
Blood. 2020 Jun 18;135(25):2323. doi: 10.1182/blood.2020006505.
4
The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.在未进行骨髓活检的情况下计算的继发性噬血细胞性淋巴组织细胞增生症的HScore，在新冠肺炎患者中一直较低。
Int J Lab Hematol. 2020 Dec;42(6):e270-e273. doi: 10.1111/ijlh.13310. Epub 2020 Aug 10.
5
Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.继发性噬血细胞性淋巴组织细胞增生症、HScore与2019冠状病毒病
Int J Hematol. 2020 Jul;112(1):125-126. doi: 10.1007/s12185-020-02895-w. Epub 2020 May 30.
6
SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.严重急性呼吸综合征冠状病毒 2 感染相关性噬血细胞性淋巴组织细胞增生症。
Am J Clin Pathol. 2020 Sep 8;154(4):466-474. doi: 10.1093/ajcp/aqaa124.
7
Hemophagocytic syndrome: a potential COVID-19 complication.噬血细胞综合征：一种潜在的新冠并发症。
J Bras Pneumol. 2020 Sep 21;46(5):e20200296. doi: 10.36416/1806-3756/e20200296.
8
Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.托珠单抗用于一名合并 COVID-19 的肾移植受者的噬血细胞综合征
Ann Intern Med. 2020 Sep 15;173(6):501-503. doi: 10.7326/L20-0419. Epub 2020 May 18.
9
Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.低剂量依托泊苷疗法对新型冠状病毒肺炎相关噬血细胞性淋巴组织细胞增生症的潜在作用
Int J Hematol. 2020 Jul;112(1):122-124. doi: 10.1007/s12185-020-02888-9. Epub 2020 May 12.
10
Reply to the letter by Gaetano Loscocco, Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.对盖埃塔诺·洛斯科科来信的回复，继发性噬血细胞性淋巴组织细胞增生症、HScore与2019冠状病毒病
Int J Hematol. 2020 Jul;112(1):127. doi: 10.1007/s12185-020-02896-9. Epub 2020 May 28.
引用本文的文献
1
Hemophagocytosis of the Hilar Pulmonary Lymph Nodes Is a More Sensitive Indicator of the Severity of COVID-19 Disease than Bone Marrow Hemophagocytosis.肺门淋巴结噬血细胞现象比骨髓噬血细胞现象更能敏感地反映COVID-19疾病的严重程度。
Diseases. 2024 Oct 3;12(10):241. doi: 10.3390/diseases12100241.
2
Severe COVID-19-associated hyperinflammatory syndrome versus classic hemophagocytic lymphohistiocytosis: similarities, differences, and the way forward.严重 COVID-19 相关的过度炎症综合征与经典噬血细胞性淋巴组织细胞增生症：相似之处、不同之处及未来方向。
J Investig Med. 2023 Mar;71(3):244-253. doi: 10.1177/10815589221140596.
3
Common bone marrow signature in COVID-19-associated multisystem inflammatory syndrome in children: A first-wave small case series experience.儿童 COVID-19 相关多系统炎症综合征的常见骨髓特征：第一波小病例系列经验。
Pediatr Blood Cancer. 2022 Nov;69(11):e29919. doi: 10.1002/pbc.29919. Epub 2022 Aug 20.
4
Animal models for COVID-19: advances, gaps and perspectives.用于 COVID-19 的动物模型：进展、差距与展望。
Signal Transduct Target Ther. 2022 Jul 7;7(1):220. doi: 10.1038/s41392-022-01087-8.
5
Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19.新冠病毒感染肺巨核细胞和血小板可预测 COVID-19 的致命性。
Cell Mol Life Sci. 2022 Jun 16;79(7):365. doi: 10.1007/s00018-022-04318-x.
6
Hemophagocytic lymphohistiocytosis diagnosed by bone marrow trephine biopsy in living post-COVID-19 patients: case report and mini-review.COVID-19 后生存患者经骨髓活检诊断噬血细胞性淋巴组织细胞增生症：病例报告及迷你综述。
J Mol Histol. 2022 Aug;53(4):753-762. doi: 10.1007/s10735-022-10088-4. Epub 2022 Jun 14.
7
A scoping review of the pathophysiology of COVID-19.COVID-19 病理生理学的范围性综述。
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211048026. doi: 10.1177/20587384211048026.
8
Association of HScore Parameters with Severe COVID-19: A Systematic Review and Meta-Analysis.HScore参数与重症新型冠状病毒肺炎的关联：一项系统评价与Meta分析
Iran J Med Sci. 2021 Sep;46(5):322-338. doi: 10.30476/IJMS.2021.88404.1910.
9
Immune thrombocytopenia in a child with COVID-19: Is it the calm after the (cytokine) storm?一名感染新冠病毒的儿童出现免疫性血小板减少症：这是（细胞因子）风暴后的平静期吗？
Pediatr Blood Cancer. 2022 Jan;69(1):e29326. doi: 10.1002/pbc.29326. Epub 2021 Sep 7.
10
Evaluation of Pathological Findings of COVID-19 by Minimally Invasive Autopsies: A Single Tertiary Care Center Experience from India.通过微创尸检评估新型冠状病毒肺炎的病理结果：来自印度一家三级医疗中心的经验
J Lab Physicians. 2021 Jun;13(2):97-106. doi: 10.1055/s-0041-1730750. Epub 2021 Jun 28.
本文引用的文献
1
Immune Thrombocytopenic Purpura in a Patient with Covid-19.一名新冠肺炎患者的免疫性血小板减少性紫癜
N Engl J Med. 2020 Apr 30;382(18):e43. doi: 10.1056/NEJMc2010472. Epub 2020 Apr 15.
2
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies.通过尸体核心活检对 2019 年新型冠状病毒病（COVID-19）的病理学研究。
Mod Pathol. 2020 Jun;33(6):1007-1014. doi: 10.1038/s41379-020-0536-x. Epub 2020 Apr 14.
3
The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis.皮质类固醇治疗冠状病毒感染患者的效果：系统评价和荟萃分析。
J Infect. 2020 Jul;81(1):e13-e20. doi: 10.1016/j.jinf.2020.03.062. Epub 2020 Apr 10.
4
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.细胞因子（包括白细胞介素 6）在 COVID-19 诱导性肺炎和巨噬细胞活化综合征样疾病中的作用。
Autoimmun Rev. 2020 Jun;19(6):102537. doi: 10.1016/j.autrev.2020.102537. Epub 2020 Apr 3.
5
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
6
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
7
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
8
Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.HScore 的制定与验证：一种用于诊断反应性噬血细胞综合征的评分系统。
Arthritis Rheumatol. 2014 Sep;66(9):2613-20. doi: 10.1002/art.38690.
9
Advances in understanding the pathogenesis of HLH.理解 HLH 发病机制的研究进展。
Br J Haematol. 2013 Jun;161(5):609-622. doi: 10.1111/bjh.12293. Epub 2013 Apr 12.
10
Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis.疑似噬血细胞性淋巴组织细胞增生症患者的诊断评估。
Br J Haematol. 2013 Feb;160(3):275-87. doi: 10.1111/bjh.12138. Epub 2012 Dec 4.
Zotero 插件